U.S. markets closed

Sanofi (SNY)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
53.80+0.02 (+0.04%)
At close: 4:00PM EDT
Show:
Balance Sheet
Cash Flow
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

Currency in EUR. All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Breakdown
ttm
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Total Revenue
36,939,000
37,369,000
37,631,000
35,677,000
36,204,000
Cost of Revenue
11,976,000
12,157,000
11,976,000
11,435,000
11,611,000
Gross Profit
24,963,000
25,212,000
25,655,000
24,242,000
24,593,000
Operating Expense
16,883,000
17,319,000
18,429,000
17,987,000
17,392,000
Operating Income
8,080,000
7,893,000
7,226,000
6,255,000
7,201,000
Net Non Operating Interest Income Expense
-347,000
-337,000
-303,000
-271,000
-273,000
Other Income Expense
6,073,000
6,248,000
-4,101,000
-1,579,000
-1,398,000
Pretax Income
13,806,000
13,804,000
2,822,000
4,405,000
5,530,000
Tax Provision
1,783,000
1,813,000
139,000
481,000
1,722,000
Earnings from Equity Interest Net of Tax
210,000
359,000
255,000
499,000
104,000
Net Income Common Stockholders
12,197,000
12,314,000
2,806,000
4,306,000
8,434,000
Diluted NI Available to Com Stockholders
12,197,000
12,314,000
2,806,000
4,306,000
8,434,000
Basic EPS
-
4.91
1.12
1.73
3.35
Diluted EPS
-
4.91
1.12
1.73
3.35
Basic Average Shares
-
2,507,200
2,499,800
2,494,200
2,513,800
Diluted Average Shares
-
2,507,200
2,499,800
2,494,200
2,513,800
Total Operating Income as Reported
14,153,000
14,141,000
3,125,000
4,676,000
5,803,000
Total Expenses
28,859,000
29,476,000
30,405,000
29,422,000
29,003,000
Net Income from Continuing & Discontinued Operation
12,197,000
12,314,000
2,806,000
4,306,000
8,434,000
Normalized Income
6,922,242
7,002,672
7,118,028
6,173,171
4,606,087
Interest Income
94,000
103,000
141,000
164,000
147,000
Interest Expense
437,000
436,000
444,000
435,000
420,000
Net Interest Income
-347,000
-337,000
-303,000
-271,000
-273,000
EBIT
14,243,000
14,240,000
3,266,000
4,840,000
5,950,000
EBITDA
15,856,000
-
-
-
-
Reconciled Cost of Revenue
11,976,000
10,154,000
6,670,000
9,326,000
9,791,000
Reconciled Depreciation
1,613,000
3,684,000
7,452,000
4,279,000
3,686,000
Net Income from Continuing Operation Net Minority Interest
12,197,000
12,314,000
2,907,000
4,319,000
3,791,000
Total Unusual Items Excluding Goodwill
6,057,000
6,112,000
-4,428,000
-2,081,000
-1,183,000
Total Unusual Items
6,057,000
6,112,000
-4,428,000
-2,081,000
-1,183,000
Normalized EBITDA
9,799,000
11,812,000
15,146,000
11,200,000
10,819,000
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
782,242
800,672
-216,972
-226,829
-367,913